Effects of clonidine on the experimental hypertension by abdominal aortic coarctation in rats

Pharmacological Research

Volumn 48, Issue 1, 2003, Pages 17-24

  Gorzalczany, Susana Beatriz ^a   Opezzo, Javier Alberto W ^a   Garcia, María Del Carmen ^a   Taira, Carlos Alberto ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Aortic coarctation; Central nervous system; Clonidine; Experimental hypertension; 2 Adrenoceptor

Indexed keywords

CLONIDINE; PENTOBARBITAL;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA COARCTATION; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART RATE; HYPERTENSION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT;

EID: 0037613646     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00058-6     Document Type: Article

References (26)

1. Salgado H.C., Fazan R., Machado B.H., Salgado M.C. Mechanical and neurohumoral factors in acute aortic coarctation hypertension. Agents Actions. 36(Suppl.):1992;152-163.
2. Michelini L., de Oliveira M., dos Santos M. Baroreceptor reflex control of heart rate during development of coarctation hypertension. Hypertension. 19(Suppl. II):1992;II159-II163.
3. Santos CM, Pontieri V, Neto ML, Michelini LC. Losartan improves baroreflex control of heart rate of coarcted hypertensive rats. Am J Physiol 1995; 269 (Heart Circ Physiol 38): H812-8.
4. Wyss J.M., Oparil S., Sripairojthikoon W. Neuronal control of the kidney: contribution to hypertension. Can. J. Physiol. Pharmacol. 70:1992;759-770.
5. Salgado H, Salgado MC. Acute aortic coarctation hypertension: role of vasopressin and angiotensin II. Am J Physiol 1989; 257 (Heart Circ Physiol 26): H1480-4.
6. Guyton J.R., Dao D.T., Lindsay K.L., Taylor A.A. Ultraestructure of hypertensive rat aorta-increased basement membrane-like material. Hypertension. 15:1990;56-67.
7. Lai F., Tanikella T., Thibault L.et al. Effect of different stages of aortic coarctation hypertension on aortic contraction and relaxation in rats. J. Pharmacol. Exp. Ther. 214:1980;388-394.
8. Salgado H.C., Skelton M.M., Salgado M.C., Cowley A.W. Jr. Physiopathogenesis of acute aortic coarctation hypertension in conscious rats. Hypertension. 23(Suppl. I):1994;I78-I81.
9. Bell D.R., Overbeck H.W. Increased resistance and impaired maximal vasodilation in normotensive vascular beds of rats with coarctation hypertension. Hypertension. 1:1979;78-85.
10. Overbeck H.W., Bell D.R., Grisstte D.E., Brock T.A. Function of the sodium pump in arterial smooth muscle in experimental hypertension: role of pressure. Hypertension. 4:1982;394-399.
11. Aksamit T.R., Floras J.S., Victor R.G., Aylward P.E. Paroxysmal hypertension due to sinoaortic barorreceptor denervation in humans. Hypertension. 9:1987;309-314.
12. Scmittt H., Schmitt-Jubeau H., Daskalopoulos N. Central mechanisms of clonidine. Trends Pharmacol. Sci. 1:1979;71-73.
13. Rojo-Ortega J.M., Genest J. A method for production of experimental hypertension in rats. Can. J. Physiol. Pharmacol. 46:1968;883-885.
14. Giuliano R., Brezenoff H.E.J. Increased centralcholinergic activity in rat models of hypertension. J. Cardiovasc. Pharmacol. 10:1987;113-122.
15. Paxinos G, Watson Ch. The rat brain in stereotaxic coordinates. 2nd ed. Academic Press: New York; 1986.
16. Brunning JL, Kintz BL. Computational Handbook of Statistics. 2nd ed. Foresman and Company: Glenview, IL, Scott; 1977.
17. Trolin G. Effects of pentobarbitone and decerebration on the clonidine-induced circulatory changes. Eur. J. Pharmacol. 34:1975;1-7.
18. Hamilton T.C., Longman S.D. A comparison of the cardiovascular and sedative actions of the α-adrenoceptor agonists, FLA-136 and clonidine, in the rat. Br. J. Pharmacol. 75:1982;13-21.
19. Gutkind J.S., Kazanietz M., Enero M.A. Cardiovascular effects of alpha-adrenergic drugs: differences between clonidine and guanabenz. Naunyn-Schmiedeberg's Arch. Pharmacol. 332:1986;370-375.
20. van Zwieten P.A., Thoolen M.J.M.C., Timmermans P.B.M.W. The hypotensive activity and side effects of methyldopa, clonidine and guanfacine. Hypertension. 6(Suppl. II):1984;II28-II33.
21. Farsang C., Ramírez-González M.D., Mucci L., Kunos G. Possible role of an endogenous opiate in the cardiovascular effects of central alpha adrenoceptor stimulation in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 214:1980;203-208.
22. Taira C.A., Enero M.A. Interaction between clonidine and physostigmine in normal rats and in rats after sinoaortic denervation. Naunyn-Schmiedberg's Arch. Pharmacol. 339:1989;522-527.
23. Boissier J.R., Giudicelli J.F., Fichelli J., Schmitt H., Schmit H. Cardiovascular effects 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system. Eur. J. Pharmacol. 2:1968;333-339.
24. Tangri K.K., Petty M., Wing L.M.H., Reid J.L. Mechanism of cardiovascular effects of clonidine in conscious and anesthetized rabbits. J. Pharmacol. Exp. Ther. 202:1977;69-75.
25. 2-adrenoceptor agonists. Eur. J. Pharmacol. 212:1992;195-200.
26. García M.C., Enero A.M., Celuch S.M. Hypotensive and hypertensive effects of catecholamines intrathecally injected in anesthetized rats. J. Autonom. Nervous Syst. 59:1996;17-26.